Pricing Log in Create free account

Estrella Immunopharma, Inc. (ESLA) vs Pasithea Therapeutics Corp. (KTTA)

Estrella Immunopharma, Inc. and Pasithea Therapeutics Corp. are both Biotechnology companies. Estrella Immunopharma, Inc. and Pasithea Therapeutics Corp. are of similar size ($17.8M and $17.4M). Across the 8 metrics below, Estrella Immunopharma, Inc. leads on 5 and Pasithea Therapeutics Corp. on 3.

Valuation

Metric ESLA KTTA Biotechnology median
P/E n/m n/m 10.60
P/S n/m 38.26 9.40
P/B n/m 0.37 2.13
Price to free cash flow n/m n/m 25.18
EV/EBITDA n/m 1.17 0.66
EV/Sales n/m (55.79) 9.02
Earnings yield (65.92%) (254.86%) (32.88%)
Free cash flow yield (58.98%) (94.76%) (23.13%)

Profitability

Metric ESLA KTTA Biotechnology median
Gross margin — 0.00% 68.51%
Operating margin 0.00% 0.00% 0.00%
Net margin 0.00% 0.00% 0.00%
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity 148.05% (65.49%) (51.96%)
Return on assets (416.74%) (61.97%) (46.06%)
Return on invested capital 0.00% (367.46%) 0.00%

Growth

Metric ESLA KTTA Biotechnology median
Revenue growth (TTM) — — 6.76%
EPS growth (last fiscal year) (188.78%) 77.07% 29.88%
Revenue growth, 5-year CAGR — — 9.75%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric ESLA KTTA Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 0.20 26.25 4.97
Net debt to EBITDA 0.11 2.74 1.01

Dividend

Metric ESLA KTTA Biotechnology median
Dividend yield — — 0.41%
Payout ratio — — —

Size

Metric ESLA KTTA Biotechnology median
Market cap 17.84m 17.38m 161.82m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack